Skip to Main Content

Residents & Fellows

Yale School of Medicine/

Yale Cancer Center

Yale Cancer Center

About Us
Patient Information
- Cancer Types
  Chênevert Family Brain Tumor Center
  Center for Breast Cancer
  Endocrine Cancers Program
  Center for Gastrointestinal Cancers
  Gynecologic Oncology Program
  Head & Neck Cancers Program
  Hematology Program
  Liver Cancer Program
  Skin & Kidney Cancer Program
  Pediatric Hematology & Oncology Program
  Prostate & Urologic Cancers Program
  Sarcoma Program
  Center for Thoracic Cancers
- Specialty Programs
  Cancer Genetics and Prevention
  Screening & Prevention
  Early Onset Cancer Program
  Early Onset Cancers
  Programs
  Resources
  Research
  PROSPER
  Cardio-Oncology
  Integrative Medicine
  Interventional Oncology
  Ocular Oncology
  Onco-Dermatology
  Pain Program
  Palliative Care
  Psycho-Oncology
  Sexuality, Intimacy & Menopause Program
  Survivorship Clinic
  Tobacco Treatment
Make a Gift
- Director's Council
- Donate Blood

Research
Diversity
Contact Us

Education & Training
News
Intranet

INFORMATION FOR

About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni

Back to Ian Krop, MD, PhD

Publications

Featured and Publish Date (Newest First)
Publish Date: Newest to Oldest
Publish Date: Oldest to Newest
Title: A-Z
Title: Z-A
Most Cited
Most Discussed

Showing 1 of 1 Publications

A phase 1 study of weekly dosing of trastuzumab emtansine (T‐DM1) in patients with advanced human epidermal growth factor 2–positive breast cancer
Beeram M, Krop IE, Burris HA, Girish SR, Yu W, Lu MW, Holden SN, Modi S. A phase 1 study of weekly dosing of trastuzumab emtansine (T‐DM1) in patients with advanced human epidermal growth factor 2–positive breast cancer. Cancer 2012, 118: 5733-5740. PMID: 22648179, DOI: 10.1002/cncr.27622.
Peer-Reviewed Original Research
MeSH Keywords and Concepts

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply

Filter By

Authors

Showing applied filters for Yale Authors:

Organizations

Showing results for Most published Organizations:

Internal Medicine(1)
Yale Cancer Center(1)
Yale School of Medicine(1)
Medical Oncology and Hematology(1)

Categories

Peer-Reviewed Original Research(1)

Publish Date

From

Month
January
February
March
April
May
June
July
August
September
October
November
December

To

Month
January
February
March
April
May
June
July
August
September
October
November
December

MeSH Keywords

Showing results for Top tagged Keywords:

Receptor, ErbB-2(1)
Breast Neoplasms(1)
Maximum Tolerated Dose(1)
Antibodies, Monoclonal, Humanized(1)
Trastuzumab(1)

Concepts

Showing applied filters for Concepts:

Showing results for Top Concepts:

Breast cancer(277)
Metastatic breast cancer(131)
Progression-free survival(79)
Patients(73)
HER2-positive breast cancer(71)

Yale Cancer Center
PO Box 208028
New Haven, CT 06520-8028
Maps & Directions
168 Events
you could attend in April 2025
Calendar
Contact Us

Intranet
Site Editor
Accessibility at YSM
Nondiscrimination & Title IX
Safety & Security
Terms & Privacy Statement
Yale University

© 2025 Yale School of Medicine

Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads

Referenced in 3 patents

102 readers on Mendeley

See more details